Table 5.
FEV1 (% predicted) at baseline and post-intramuscular triamcinolone acetonide (TA) administration in BPS-low (below median BPS) and BPS-high (above median) patients
| Visit |
|||
|---|---|---|---|
| Group | Baseline | Post-TA | p |
| Below median/BPS-low (27) | 84 ± 19 | 87 ± 20 | 0.002 |
| Above median/BPS-high (27) | 74 ± 22 | 75 ± 22* | 0.43 |
Data are presented as mean ± SD. FEV1 = pre-bronchodilation FEV1. BPS, baseline P-selectin; FEV1, forced expiratory volume in 1 s.
p ≤ 0.05 versus BPS-low (< 23.1 ng/ml).